supplementary tables.docx (17.22 kB)
supplementary tables: Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA.docx
dataset
posted on 2021-07-14, 12:51 authored by Ahmed Shelbaya, John M Kelton, Jeffrey Thompson, Jose MJ Alvir, Martine C Maculaitis, Jingyan Yang|
Supplementary Table 1. Definitions of Dosing and Treatment Patterns Variables Supplementary Table 2. Treatment Utilization Patterns of Rituximab-pvvr in Patients with NHL and CLL |
